Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Biostatistics: Overview01:20

Biostatistics: Overview

239
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
239
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

123
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
123

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preserving a Functional Foot: Limb-Salvage Surgery with Brachy Mono-Therapy for Soft Tissue Sarcoma.

Indian journal of surgical oncology·2026
Same author

What is meant when we say we are clustering multimorbidity?

The lancet. Healthy longevity·2026
Same author

Cardiometabolic multiple long-term conditions: a tractable focus for a field challenged by heterogeneity?

Lancet (London, England)·2026
Same author

Correction to: From Dry Cavities to Healing Pathways: Innovations in Managing Empty Nose Syndrome.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2026
Same author

Accelerated deficit accumulation in frailty and associations with adverse outcomes: a longitudinal population data analysis.

The lancet. Healthy longevity·2026
Same author

Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay.

JAMA cardiology·2026
Same journal

P2Y12-P-selectin-mediated platelet activation in a murine model of dengue-associated thrombocytopenia.

EBioMedicine·2026
Same journal

Inosine accumulation in hydrosalpinx fluid: a metabolic barrier to early embryonic development.

EBioMedicine·2026
Same journal

Multi-modal single-cell sequencing reveals network transition in circulating monocytes that aligns with faster recovery in patients with trauma and favours a response to M-CSF.

EBioMedicine·2026
Same journal

HCV-specific CD4<sup>+</sup> T-cells are susceptible to HIV-1 and contribute to viral persistence during antiretroviral therapy.

EBioMedicine·2026
Same journal

Effects of exercise and exercise timing on energy intake and appetite control: a randomised crossover trial in people with overweight or obesity with and without type 2 diabetes.

EBioMedicine·2026
Same journal

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

EBioMedicine·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2025

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Multimorbidity analysis with low condition counts: a robust Bayesian approach for small but important subgroups.

Guillermo Romero Moreno1, Valerio Restocchi1, Jacques D Fleuriot1

  • 1School of Informatics, University of Edinburgh, Edinburgh, UK.

Ebiomedicine
|March 22, 2024
PubMed
Summary
This summary is machine-generated.

A new Bayesian framework improves the analysis of long-term condition associations in older adults, even with limited data. This approach enhances the reliability of multimorbidity research and disease mechanism studies.

Keywords:
Association measuresBayesian inferenceLow countsMultimorbidityNetwork analysisRelative risk

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

Related Experiment Videos

Last Updated: Jun 30, 2025

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

Area of Science:

  • Gerontology
  • Biostatistics
  • Epidemiology

Background:

  • Examining long-term condition associations is vital for multimorbidity intervention but challenging with sparse data.
  • The oldest old population presents unique challenges due to limited available data on comorbidities.

Purpose of the Study:

  • To develop and apply a Bayesian inference framework robust to sparse data for quantifying morbidity associations.
  • To compare the proposed Associations Beyond Chance (ABC) measure with standard Relative Risk (RR) in analyzing comorbidity networks.

Main Methods:

  • Retrospective cross-sectional study of 12,009 primary care patients aged 90+ in Scotland (March 2007).
  • Analysis of 40 long-term conditions, stratified by sex, comparing RR and the novel ABC measure.
  • Construction of association networks to explore condition interactions and differences between RR and ABC estimations.

Main Results:

  • The Bayesian framework demonstrated appropriate caution with sparse data, especially for uncommon conditions.
  • This cautious approach impacted aggregated multimorbidity measures and network representations, including sex-specific differences.
  • Differences in association analysis were observed when using RR versus ABC estimations.

Conclusions:

  • Incorporating uncertainty is crucial in multimorbidity research to prevent misleading findings in small subgroups.
  • The proposed Bayesian framework enhances the reliability of association estimations and research into disease mechanisms and multimorbidity.